C.A. Carter
Walter Reed National Military Medical Center · 4 works · 259 citations · h-index 3
Top works
- A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
- Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer
- Phase I/II trial of X-396 in patients (pts) with ALK+ non-small cell lung cancer (NSCLC): Correlation with plasma and tissue genotyping and response to therapy (tx)
- PS02.24 RRx-001 Priming in Patients with Previously Treated SCLC (QUADRUPLE THREAT)